Navigation Links
Surprise Cure for Marfan syndrome

Marfan syndrome is a genetic disorder that affects the heart's largest artery, the aorta. Studies were going on to get to the bottom of the disease and researchers at Johns Hopkins University// have successfully come up with the treatment. Cozaar is the blood-pressure drug that has shown promise in recent studies for treating the genetic disorder. The researchers at Johns Hopkins University said that the Merck's drug appears to prevent the weakening of the heart's largest artery, the aorta.

Researcher Harry Dietz, said that this drug has the ability to prevent rather than attenuate or respond to manifestations of this disease. The results of the new studies were published in the journal Science. He said that this drug not only prevents the aorta from weakening but also seems to heal the artery if it's already been damaged.

Statistics shows that Marfan syndrome approximately affects 30,000 people in the United States. The main feature of this disease is that patients live with the constant risk of sudden death if his or her weakened aorta bursts. Experts believe that thousands of Americans remain undiagnosed with the condition.


'"/>




Page: 1

Related medicine news :

1. Sweaty palms syndrome can be cured by surgery
2. Treatment for pre-menstrual syndrome is ineffective
3. Artists prone to cubital tunnel syndrome
4. Shelved bowel-syndrome drug still in demand
5. Down syndrome life anticipation doubles
6. Restless leg syndrome can be a family trait
7. Restless leg syndrome may remain under-diagnosed in many
8. Calcium and Vitamin D reduces risk of Premenstrual syndrome
9. Warding off symptoms of premenstrual syndrome by combination therapy
10. Roots of polycystic ovarian syndrome traced to mother’s wom
11. Substance abuse linked to adult antisocial syndrome
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The American ... to become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer ... Elect beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. ...
(Date:10/13/2017)... Las Vegas, Nevada (PRWEB) , ... October 13, 2017 , ... ... of 7® Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum ... CBD dose required and providing a CBD form that can be easily incorporated into ...
(Date:10/13/2017)... QUEENS, N.Y (PRWEB) , ... October 13, 2017 , ... ... recently became a member of ElderCounsel, a national organization of elder law and special ... constantly changing laws and rules. It also provides a forum to network with elder ...
(Date:10/13/2017)... Calif. (PRWEB) , ... October 13, 2017 , ... Many ... dementia. However, many long-term care insurance companies have a waiver for care if the ... 90-day elimination period, when the family pays for care, is often waived, so the ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for ... for action towards gender equality at their inaugural Summit in New York City in ... reached a social audience of over 3 million. To watch the Mobilize Women video, ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... announces the European launch of their new low volume, high throughput ... Cambridge, U.K on October 4th. The new ... unprecedented speed and sensitivity while using far less sample volume through ... ... ...
(Date:9/28/2017)... -- Hill-Rom Holdings, Inc. (NYSE: HRC), will host its ... on Friday, November 3, 2017, beginning at 7:00 a.m. ... 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... and guidance for 2018, Hill-Rom executives will also highlight ... and long-range financial outlook through 2020. ...
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion to ... awards. Ranked as number one in the South Florida Business ... in Inc. 5000 yearly list, the national specialty pharmacy has ... Armando Bardisa will soon be honored by SFBJ as ... Set to receive his award in October, ...
Breaking Medicine Technology: